Conflu3nce (קנפלו3נץ)

Jerusalem, Israel

Alzheimer(s) DiseaseDiagnosticsNeurology

Conflu3nce applies patented and patent-pending methods to develop diagnostic, treatment, and rehabilitation tools to increase the capacity of people affected by visual-processing and visual-cognition differences and deficits. Conflu3nce is currently developing a minimally disruptive, non-pharmaceutical approach to address attention, executive function, and visual-cognition-related issues for people with Alzheimer's disease, traumatic brain injury, stroke, and attention deficit/hyperactivity disorder. The system's multi-modal, multi-domain-based activities are designed to cooperatively engage global cognition and can be delivered as hands-on and virtual/view-only experiences. The company's technology, the PICSS Interactive platform, is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated. Users are guided through a series of progressively challenging interactions designed to help cooperatively develop and retrain skills, processes, and processing. Through therapeutic gameplay, PICSS Interactive users can improve their eye-tracking skills and associated visual-cognition processes including memory, pattern recognition, scanning, visual attention, and closure.